Total Payments
$1,344
2024 Payments
$336.90
Companies
25
Transactions
66
Medicare Patients
313
Medicare Billing
$49,583
Payment Breakdown by Category
Food & Beverage$1,344 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,344 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $212.94 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $195.60 | 10 | $0 (2023) |
| Incyte Corporation | $114.33 | 5 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $108.55 | 5 | $0 (2023) |
| ABBVIE INC. | $103.88 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $80.25 | 3 | $0 (2024) |
| Legend Biotech USA Inc. | $77.36 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $68.72 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $57.74 | 4 | $0 (2023) |
| Genmab U.S., Inc. | $41.64 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.90 | 16 | Celgene Corporation ($54.64) |
| 2023 | $662.89 | 31 | Celgene Corporation ($105.28) |
| 2022 | $276.84 | 16 | Janssen Biotech, Inc. ($67.33) |
| 2021 | $66.95 | 3 | Janssen Biotech, Inc. ($43.37) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: BioOncology | ||||||
| 11/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $31.80 | General |
| Category: Hematology | ||||||
| 11/07/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $13.87 | General |
| 09/17/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.84 | General |
| Category: Hematology | ||||||
| 09/06/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/29/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $22.55 | General |
| 05/08/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $20.66 | General |
| 04/08/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Infectious Diseases | ||||||
| 01/19/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: Hematology/Oncology | ||||||
| 01/11/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Oncology | ||||||
| 12/19/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/18/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: Hematology/Oncology | ||||||
| 11/15/2023 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
| 11/10/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: Hematology | ||||||
| 10/20/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Oncology | ||||||
| 09/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 92 | $42,224 | $8,635 |
| 2022 | 2 | 86 | 122 | $46,921 | $14,522 |
| 2021 | 4 | 117 | 177 | $63,109 | $18,043 |
| 2020 | 2 | 58 | 90 | $31,016 | $8,383 |
Total Patients
313
Total Services
481
Medicare Billing
$49,583
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 43 | $23,355 | $4,715 | 20.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 49 | $18,869 | $3,920 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 111 | $41,916 | $13,146 | 31.4% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 11 | 11 | $5,005 | $1,376 | 27.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 116 | $43,796 | $14,370 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 28 | $7,840 | $2,405 | 30.7% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 20 | 22 | $10,010 | $1,173 | 11.7% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 11 | 11 | $1,463 | $93.94 | 6.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 60 | $22,560 | $6,103 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 30 | $8,456 | $2,280 | 27.0% |
About Hannah Davidson, NP
Hannah Davidson, NP is a Registered Nurse healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1467005199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hannah Davidson, NP has received a total of $1,344 in payments from pharmaceutical and medical device companies, with $336.90 received in 2024. These payments were reported across 66 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,344).
As a Medicare-enrolled provider, Davidson has provided services to 313 Medicare beneficiaries, totaling 481 services with total Medicare billing of $49,583. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Registered Nurse, Adult Health
- Location Denver, CO
- Active Since 07/22/2019
- Last Updated 12/23/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1467005199
Products in Payments
- REBLOZYL (Biological) $199.54
- IMBRUVICA (Drug) $162.54
- JAKAFI (Drug) $114.33
- DARZALEX (Biological) $113.14
- SCEMBLIX (Drug) $55.76
- EPKINLY (Drug) $53.23
- Xospata (Drug) $49.74
- VENCLEXTA (Drug) $43.86
- PREVYMIS (Drug) $43.13
- Epkinly (Drug) $41.64
- BOTOX (Biological) $35.26
- CARVYKTI (Biological) $34.15
- VONJO (Drug) $28.08
- LONSURF (Drug) $26.52
- TASIGNA (Drug) $24.49
- REZUROCK (Drug) $23.37
- BRUKINSA (Drug) $23.26
- Tazverik (Drug) $21.91
- CALQUENCE (Drug) $19.55
- Cresemba (Drug) $18.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Denver
Jose Diaz Leo, Np-C, NP-C
Registered Nurse — Payments: $20,349
Registered Nurse $20,349
Noreedn Nicol, Np, NP
Registered Nurse — Payments: $16,991
Registered Nurse $16,991
Gina Fidler, Np, NP
Registered Nurse — Payments: $5,867
Registered Nurse $5,867
Dr. Jamie Mccartney Herbert, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $2,707
Registered Nurse $2,707
Nataliya Hayes
Registered Nurse — Payments: $2,656
Registered Nurse $2,656
Peter Prutch, Np, NP
Registered Nurse — Payments: $2,646
Registered Nurse $2,646